title: 5% Minoxidil: treatment for female pattern hair loss.
abstract: Minoxidil is a Health Canada and US FDA-approved medication for hair loss in men and women. While 5% minoxidil foam has been approved for men since 2006, Health Canada and the FDA only approved 5% minoxidil foam for female pattern hair loss (FPHL) in 2014. Recent Phase III clinical trials demonstrated the efficacy of once daily 5% minoxidil foam for treatment of FPHL, where a significant change from baseline in the target area hair count was observed compared to placebo. Similar changes in hair count for 5% foam and twice daily 2% minoxidil solution established noninferiority of the 5% foam formulation. Five percent minoxidil foam provides an additional option for women with FPHL and will soon be available in Canada.
authors: Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada; Mediprobe Research Inc., London, ON, Canada.
authors: Aditya K
authors: AK
authors: Gupta
authors: Mediprobe Research Inc., London, ON, Canada.
authors: Kelly A
authors: KA
authors: Foley
mesh_terms: D000505:Alopecia / Q000188:drug therapy*; D002170:Canada; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008914:Minoxidil / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
chemical_list: D008914:Minoxidil